MXPA02010338A - Granulos efervescentes y metodos para su preparacion. - Google Patents
Granulos efervescentes y metodos para su preparacion.Info
- Publication number
- MXPA02010338A MXPA02010338A MXPA02010338A MXPA02010338A MXPA02010338A MX PA02010338 A MXPA02010338 A MX PA02010338A MX PA02010338 A MXPA02010338 A MX PA02010338A MX PA02010338 A MXPA02010338 A MX PA02010338A MX PA02010338 A MXPA02010338 A MX PA02010338A
- Authority
- MX
- Mexico
- Prior art keywords
- granules
- agent
- agents
- pharmacologically active
- effervescent
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 230000002378 acidificating effect Effects 0.000 abstract 2
- 239000004081 narcotic agent Substances 0.000 abstract 2
- 125000001792 phenanthrenyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 abstract 2
- DYUTXEVRMPFGTH-UHFFFAOYSA-N 4-(2,5-dimethylphenyl)-5-methyl-1,3-thiazol-2-amine Chemical compound S1C(N)=NC(C=2C(=CC=C(C)C=2)C)=C1C DYUTXEVRMPFGTH-UHFFFAOYSA-N 0.000 abstract 1
- 239000000674 adrenergic antagonist Substances 0.000 abstract 1
- 239000003529 anticholesteremic agent Substances 0.000 abstract 1
- 229940127226 anticholesterol agent Drugs 0.000 abstract 1
- 229940125714 antidiarrheal agent Drugs 0.000 abstract 1
- 239000003793 antidiarrheal agent Substances 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000000374 eutectic mixture Substances 0.000 abstract 1
- 238000009474 hot melt extrusion Methods 0.000 abstract 1
- 239000012943 hotmelt Substances 0.000 abstract 1
- 229960002738 hydromorphone hydrochloride Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical class O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 1
- 229960004715 morphine sulfate Drugs 0.000 abstract 1
- GRVOTVYEFDAHCL-RTSZDRIGSA-N morphine sulfate pentahydrate Chemical compound O.O.O.O.O.OS(O)(=O)=O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O GRVOTVYEFDAHCL-RTSZDRIGSA-N 0.000 abstract 1
- -1 morphine sulfate) Chemical class 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/553,528 US6649186B1 (en) | 1996-09-20 | 2000-04-20 | Effervescent granules and methods for their preparation |
PCT/EP2001/005017 WO2001080822A2 (en) | 2000-04-20 | 2001-04-20 | Effervescent granules and methods for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02010338A true MXPA02010338A (es) | 2003-12-11 |
Family
ID=24209766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02010338A MXPA02010338A (es) | 2000-04-20 | 2001-04-20 | Granulos efervescentes y metodos para su preparacion. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6649186B1 (es) |
EP (1) | EP1274398B1 (es) |
JP (1) | JP5063848B2 (es) |
KR (1) | KR20030011829A (es) |
CN (1) | CN100337613C (es) |
AT (1) | ATE410145T1 (es) |
AU (2) | AU2001254826B2 (es) |
BG (1) | BG65877B1 (es) |
CA (1) | CA2406833C (es) |
CZ (1) | CZ20023419A3 (es) |
DE (1) | DE60136057D1 (es) |
DK (1) | DK1274398T3 (es) |
HU (1) | HU230267B1 (es) |
IL (1) | IL152317A (es) |
MX (1) | MXPA02010338A (es) |
NO (1) | NO333395B1 (es) |
SK (1) | SK287187B6 (es) |
WO (1) | WO2001080822A2 (es) |
ZA (1) | ZA200208456B (es) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7747592B2 (en) * | 1999-09-07 | 2010-06-29 | Thomas C Douglass | Method and system for monitoring domain name registrations |
US9311399B2 (en) | 1999-09-07 | 2016-04-12 | C. Douglass Thomas | System and method for providing an updating on-line forms and registrations |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
CA2415957C (en) * | 2000-06-23 | 2010-08-10 | Bioprojet | Dry powder formulation comprising racecadotril |
FR2823668B1 (fr) * | 2001-04-20 | 2004-02-27 | Ethypharm Lab Prod Ethiques | Comprimes effervescents orodispersibles |
US20040157876A1 (en) * | 2001-05-21 | 2004-08-12 | Elema Michiel O | Granular preparations of gaboxadol |
US6645526B2 (en) | 2001-11-13 | 2003-11-11 | Mylan Pharmaceuticals, Inc. | Storage stable thyroxine active drug formulations and methods for their production |
US20030099699A1 (en) * | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
GB0129117D0 (en) * | 2001-12-05 | 2002-01-23 | Glaxo Group Ltd | Pharmaceutical composition |
AU2002353659A1 (en) * | 2001-12-18 | 2003-07-15 | Synthon B.V. | Simvastatin dosage forms |
US7233550B2 (en) | 2002-09-30 | 2007-06-19 | Lg Electronics Inc. | Write-once optical disc, and method and apparatus for recording management information on write-once optical disc |
TWI314315B (en) | 2003-01-27 | 2009-09-01 | Lg Electronics Inc | Optical disc of write once type, method, and apparatus for managing defect information on the optical disc |
CA2527368A1 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Pharmaceutical composition |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
TR200301614A2 (tr) * | 2003-09-26 | 2005-10-21 | Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem |
WO2005044193A2 (en) * | 2003-10-28 | 2005-05-19 | Spi Pharma, Inc. | Product and process for increasing compactibility of carbohydrates |
US7862833B2 (en) * | 2003-12-31 | 2011-01-04 | Cima Labs, Inc. | Effervescent oral opiate dosage forms and methods of administering opiates |
CA2548915C (en) | 2003-12-31 | 2012-10-16 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
WO2005077341A1 (en) * | 2004-01-19 | 2005-08-25 | Ranbaxy Laboratories Limited | Orally disintegrating pharmaceutical compositions of ondansetron |
AT500101A1 (de) * | 2004-02-04 | 2005-10-15 | Tritthart Thomas | Verkapselungsprozess |
US8216610B2 (en) * | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
KR100574554B1 (ko) * | 2004-05-28 | 2006-04-27 | 한미약품 주식회사 | 니아신의 경구투여용 서방성 조성물 |
PL1799195T3 (pl) * | 2004-08-12 | 2016-09-30 | Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału | |
US20060039972A1 (en) * | 2004-08-19 | 2006-02-23 | Mary Aldritt | Effervescent composition including a grape-derived component |
DE102004042139B4 (de) * | 2004-08-31 | 2009-06-10 | Aristocon Verwaltungs- Gmbh | Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit |
MX2007002781A (es) * | 2004-09-09 | 2009-02-12 | Bayer Animal Health Gmbh | Composición farmacéutica. |
JP5124267B2 (ja) | 2005-02-25 | 2013-01-23 | 武田薬品工業株式会社 | 顆粒の製造方法 |
JP2007015966A (ja) * | 2005-07-06 | 2007-01-25 | Fujimoto Corporation:Kk | 口腔内崩壊錠 |
AU2006301919B2 (en) * | 2005-10-07 | 2011-09-22 | Kalinda Nominees Pty Ltd | Preparation for the treatment of diarrhoea |
KR20080070848A (ko) * | 2005-11-03 | 2008-07-31 | 레드포인트 바이오 코포레이션 | 히드라존 유도체 및 이의 용도 |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
EP1954298A4 (en) | 2005-11-28 | 2012-10-31 | Imaginot Pty Ltd | DISPENSING SYSTEM FOR ORAL THERAPEUTIC CONNECTION |
WO2007075408A2 (en) * | 2005-12-16 | 2007-07-05 | Effrx, Inc. | Effervescent compositions for triptans |
AU2007230730B2 (en) | 2006-03-24 | 2013-03-28 | Auxilium International Holdings, Inc. | Stabilized compositions containing alkaline labile drugs |
CN101489756B (zh) * | 2006-03-24 | 2013-08-07 | 奥克思利尤姆国际控股公司 | 热熔挤出层压材料的制备方法 |
BRPI0602825A2 (pt) * | 2006-06-23 | 2012-04-24 | Rhodia Br Ltda | formulação de pó efervescente auto-refrigerante para bebidas e uso de formulação em pó efervescente |
CN1994296B (zh) * | 2006-08-02 | 2010-06-16 | 浙江京新药业股份有限公司 | 一种含有辛伐他汀的药物制剂 |
BRPI0716053A2 (pt) * | 2006-08-22 | 2013-08-06 | Redpoint Bio Corp | compostos heterocÍclicos como promotores de adoÇantes |
WO2008033545A2 (en) * | 2006-09-15 | 2008-03-20 | Redpoint Bio Corporation | Triphenylphosphine oxide derivatives and uses thereof |
US20080153845A1 (en) * | 2006-10-27 | 2008-06-26 | Redpoint Bio Corporation | Trpv1 antagonists and uses thereof |
BRPI0808157A2 (pt) * | 2007-02-02 | 2014-07-01 | Redpoint Bio Corp | Uso de inibidor de trpm5 para regular insulina e a liberação de glp-1 |
US20090028802A1 (en) * | 2007-07-23 | 2009-01-29 | Toru Hibi | Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same |
EP2293779A1 (en) * | 2008-04-24 | 2011-03-16 | Evestra, Inc. | Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen |
FR2938431B1 (fr) | 2008-11-14 | 2013-12-20 | Debregeas Et Associes Pharma | Nouvelle composition a base d'acide gamma-hydroxybutyrique |
WO2010086989A1 (ja) | 2009-01-29 | 2010-08-05 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
US20100215758A1 (en) * | 2009-02-25 | 2010-08-26 | Joar Opheim | Effervescent nutritional and/or dietary supplement composition |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
AU2010265866B2 (en) | 2009-06-26 | 2012-07-12 | Taris Biomedical Llc | Solid drug tablets for implantable drug delivery devices |
CN101966165B (zh) * | 2009-07-14 | 2012-06-13 | 无锡健而乐医药科技有限公司 | 口腔吸收固体泡腾制剂 |
FR2949061B1 (fr) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
FR2949062B1 (fr) | 2009-08-12 | 2011-09-02 | Debregeas Et Associes Pharma | Nouvelles formulations pharmaceutiques contre le mesusage des medicaments |
AU2010284028A1 (en) * | 2009-08-17 | 2012-03-29 | Waxtabs (Pty) Ltd | Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith |
SG178376A1 (en) | 2009-09-04 | 2012-03-29 | Redpoint Bio Corp | Sweetness enhancers including rebaudioside a or d |
US20120230922A1 (en) | 2009-09-22 | 2012-09-13 | Redpoint Bio Corporation | Novel Polymorphs of Rebaudioside C and Methods for Making and Using the Same |
JP5751868B2 (ja) | 2010-03-30 | 2015-07-22 | 日東電工株式会社 | フィルム状製剤及びその製造方法 |
WO2011146030A2 (en) * | 2010-05-18 | 2011-11-24 | Mahmut Bilgic | Effervescent antihistamine formulations |
US20130108745A1 (en) * | 2010-07-01 | 2013-05-02 | Delante Health As | Coated effervescent tablet |
FR2962331B1 (fr) * | 2010-07-06 | 2020-04-24 | Ethypharm | Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre |
FR2962550B1 (fr) * | 2010-07-06 | 2013-06-14 | Ethypharm Sa | Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode |
CA2805568A1 (en) * | 2010-07-08 | 2012-01-12 | Ratiopharm Gmbh | Oral dosage form of deferasirox |
CN103987840A (zh) | 2011-08-08 | 2014-08-13 | 国际香料香精公司 | 用于香草醛或香草醛β-D-葡萄糖苷的生物合成的组合物和方法 |
WO2013077851A1 (en) * | 2011-11-22 | 2013-05-30 | Watson Pharmaceuticals, Inc. | Immediate release abuse deterrent tablet |
CN102525944A (zh) * | 2012-01-11 | 2012-07-04 | 扬子江药业集团广州海瑞药业有限公司 | 枸地氯雷他定颗粒及其制备方法 |
JP5841433B2 (ja) * | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
EP2649989B1 (en) * | 2012-04-13 | 2017-10-18 | King Saud University | Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof |
US20150231101A1 (en) | 2012-08-20 | 2015-08-20 | Merck Patent Gmbh | Solid pharmaceutical preparation containing levothyroxine |
SG10201707528WA (en) | 2013-03-15 | 2017-10-30 | Tonix Pharmaceuticals Inc | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride |
US11058642B2 (en) | 2013-04-22 | 2021-07-13 | Tower Laboratories Ltd | Tablets with improved friability |
EP2880992A3 (en) | 2013-12-05 | 2015-06-17 | International Flavors & Fragrances Inc. | Rebaudioside C and its stereoisomers as natural product sweetness enhancers |
JP2017508762A (ja) | 2014-03-28 | 2017-03-30 | ガルデルマ・リサーチ・アンド・デヴェロップメント | 過酸化ベンゾイルを含有するすすがない化学的ムース剤 |
GB201411802D0 (en) * | 2014-07-02 | 2014-08-13 | Univ Bradford | Effervescent compositions |
WO2016042372A1 (en) * | 2014-09-17 | 2016-03-24 | Steer Engineering Private Limited | Effervescent composition and method of making it |
CN104434863B (zh) * | 2014-11-13 | 2017-05-24 | 武汉大学 | 一种盐酸丁卡因口腔泡腾片及其制备方法 |
JP6682385B2 (ja) * | 2015-07-01 | 2020-04-15 | 花王株式会社 | 固形状組成物 |
FR3041536B1 (fr) | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne. |
FR3041535B1 (fr) | 2015-09-29 | 2019-01-25 | Galderma Research & Development | Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose. |
FR3041537B1 (fr) | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee. |
FR3041538B1 (fr) | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis. |
FR3041539B1 (fr) | 2015-09-29 | 2018-10-26 | Galderma Research & Development | Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis. |
FR3041541B1 (fr) * | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee comprenant de l'ivermectine |
WO2017098481A1 (en) | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
EP3723860A1 (en) | 2017-12-11 | 2020-10-21 | Tonix Pharma Holdings Limited | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions |
CN110075072A (zh) * | 2019-05-24 | 2019-08-02 | 山东新华制药股份有限公司 | 一种布洛芬赖氨酸泡腾颗粒的制备方法 |
US20200405673A1 (en) * | 2019-06-25 | 2020-12-31 | NuBioPharma, LLC | Oral solution and powder to liquid compositions of balsalazide |
FR3099881B1 (fr) * | 2019-08-13 | 2022-08-26 | Ethypharm Sa | Comprimé orodispersible d’opioide à faible dosage et son procédé de préparation. |
CN114146061B (zh) * | 2020-09-07 | 2023-06-30 | 歌礼生物科技(杭州)有限公司 | 包含固体分散体的蛋白酶抑制剂增效组合物及其制备方法 |
US20220287303A1 (en) * | 2021-03-14 | 2022-09-15 | LMA Solutions, Inc. | Compositions and methods for disinfecting removable dental appliances |
CN117441898B (zh) * | 2023-12-22 | 2024-04-12 | 山东天力药业有限公司 | 一种维生素c泡腾颗粒及其制备方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1262888A (en) | 1917-02-20 | 1918-04-16 | Albert Westlake | Mouth-tablet. |
GB917456A (en) | 1958-10-30 | 1963-02-06 | Casco Lab Inc | Suppository composition and preparation thereof |
DE1467938C3 (de) | 1964-05-22 | 1973-12-20 | F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) | Wasserdispergierbares Arzneipräparat für Tiere |
US3667929A (en) | 1969-07-30 | 1972-06-06 | George W Fleming Jr | Method of effecting dissolution of solutes in water and compositions therefor |
US3962417A (en) | 1974-03-27 | 1976-06-08 | Howell Charles J | Dentifrice |
US4153678A (en) | 1978-07-17 | 1979-05-08 | American Cyanamid Company | Levamisole effervescent tablets |
US4267164A (en) | 1980-01-31 | 1981-05-12 | Block Drug Company Inc. | Effervescent stannous fluoride tablet |
US4613497A (en) | 1984-02-29 | 1986-09-23 | Health Products Development, Inc. | Dry, water-foamable pharmaceutical compositions |
US4725427A (en) | 1984-03-13 | 1988-02-16 | Albion International, Inc. | Effervescent vitamin-mineral granule preparation |
GB8421226D0 (en) | 1984-08-21 | 1984-09-26 | Int Conferences Ab | Tooth cleaning tablet |
US4639368A (en) | 1984-08-23 | 1987-01-27 | Farmacon Research Corporation | Chewing gum containing a medicament and taste maskers |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4639458A (en) | 1985-01-22 | 1987-01-27 | Merck & Co., Inc. | Tablet and formulation |
JPS61183219A (ja) | 1985-02-07 | 1986-08-15 | Takeda Chem Ind Ltd | 発泡組成物の製造法 |
US4687662A (en) | 1985-08-30 | 1987-08-18 | Warner-Lambert Company | Therapeutic effervescent composition |
US4797275A (en) | 1985-09-26 | 1989-01-10 | Eli Lilly And Company | Nicarbazin feed premix |
GB8724763D0 (en) | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
GB8909793D0 (en) | 1989-04-28 | 1989-06-14 | Beecham Group Plc | Pharmaceutical formulation |
US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
FR2653013B1 (fr) | 1989-10-13 | 1992-01-10 | Oreal | Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en óoeuvre dudit procede et traitement cosmetique correspondant. |
EP0443381B2 (en) * | 1990-02-14 | 1997-10-22 | Takeda Chemical Industries, Ltd. | Effervescent composition, its production and use |
JP3180359B2 (ja) * | 1991-02-28 | 2001-06-25 | 日本曹達株式会社 | 錠剤様発泡性農薬組成物の製造法 |
RU2096955C1 (ru) * | 1991-03-01 | 1997-11-27 | Е.И.Дюпон Де Немур Энд Компани | Вододиспергируемая гранулированная пестицидная композиция, получаемая методом экструзии, и способ ее получения |
GB2307857B (en) * | 1995-12-04 | 1999-01-27 | Euro Celtique Sa | An effervescent formulation |
US6071539A (en) * | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
DE19822036A1 (de) * | 1998-05-15 | 1999-11-18 | Bayer Ag | Brausezubereitungen |
GB2355511A (en) | 1999-07-15 | 2001-04-25 | Air Prod & Chem | Freezing products |
-
2000
- 2000-04-20 US US09/553,528 patent/US6649186B1/en not_active Expired - Lifetime
-
2001
- 2001-04-20 AU AU2001254826A patent/AU2001254826B2/en not_active Ceased
- 2001-04-20 WO PCT/EP2001/005017 patent/WO2001080822A2/en active Application Filing
- 2001-04-20 DK DK01927938T patent/DK1274398T3/da active
- 2001-04-20 CA CA002406833A patent/CA2406833C/en not_active Expired - Fee Related
- 2001-04-20 SK SK1510-2002A patent/SK287187B6/sk not_active IP Right Cessation
- 2001-04-20 CZ CZ20023419A patent/CZ20023419A3/cs unknown
- 2001-04-20 MX MXPA02010338A patent/MXPA02010338A/es active IP Right Grant
- 2001-04-20 KR KR1020027014142A patent/KR20030011829A/ko not_active Application Discontinuation
- 2001-04-20 CN CNB018114687A patent/CN100337613C/zh not_active Expired - Fee Related
- 2001-04-20 AT AT01927938T patent/ATE410145T1/de not_active IP Right Cessation
- 2001-04-20 HU HU0300432A patent/HU230267B1/hu not_active IP Right Cessation
- 2001-04-20 IL IL152317A patent/IL152317A/en not_active IP Right Cessation
- 2001-04-20 DE DE60136057T patent/DE60136057D1/de not_active Expired - Lifetime
- 2001-04-20 JP JP2001577922A patent/JP5063848B2/ja not_active Expired - Fee Related
- 2001-04-20 AU AU5482601A patent/AU5482601A/xx active Pending
- 2001-04-20 EP EP01927938A patent/EP1274398B1/en not_active Expired - Lifetime
-
2002
- 2002-10-14 BG BG107193A patent/BG65877B1/bg unknown
- 2002-10-15 NO NO20024947A patent/NO333395B1/no not_active IP Right Cessation
- 2002-10-18 ZA ZA200208456A patent/ZA200208456B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP5063848B2 (ja) | 2012-10-31 |
CA2406833C (en) | 2009-06-30 |
IL152317A (en) | 2010-05-31 |
HU230267B1 (hu) | 2015-11-30 |
ATE410145T1 (de) | 2008-10-15 |
IL152317A0 (en) | 2003-05-29 |
HUP0300432A2 (hu) | 2003-07-28 |
SK15102002A3 (sk) | 2003-06-03 |
WO2001080822A3 (en) | 2002-03-28 |
CN1437462A (zh) | 2003-08-20 |
DK1274398T3 (da) | 2009-02-16 |
HUP0300432A3 (en) | 2005-02-28 |
ZA200208456B (en) | 2003-10-20 |
EP1274398B1 (en) | 2008-10-08 |
NO20024947D0 (no) | 2002-10-15 |
AU5482601A (en) | 2001-11-07 |
JP2003531161A (ja) | 2003-10-21 |
CA2406833A1 (en) | 2001-11-01 |
BG65877B1 (bg) | 2010-04-30 |
NO333395B1 (no) | 2013-05-27 |
KR20030011829A (ko) | 2003-02-11 |
AU2001254826B2 (en) | 2006-03-16 |
DE60136057D1 (de) | 2008-11-20 |
WO2001080822A2 (en) | 2001-11-01 |
US6649186B1 (en) | 2003-11-18 |
SK287187B6 (sk) | 2010-02-08 |
NO20024947L (no) | 2002-12-12 |
CZ20023419A3 (cs) | 2003-05-14 |
BG107193A (bg) | 2003-06-30 |
CN100337613C (zh) | 2007-09-19 |
EP1274398A2 (en) | 2003-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5482601A (en) | Effervescent granules and methods for their preparation | |
HUP0302167A3 (en) | Quinoline derivatives as metabotropic glutamate receptor antagonists, pharmaceutical compositions containing them and process for producing them | |
HUP0204170A3 (en) | 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient | |
MY130803A (en) | New quinuclidine amide derivatives | |
HUP0402588A3 (en) | Quinazoline derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
CA2280447A1 (en) | Pyrrolo¬1,2-a|pyrazine derivatives as 5ht1a ligands | |
AU1529402A (en) | Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor | |
HUP9601884A2 (en) | 6-(dimethylamino-methyl)-1-phenyl-cyclohexane compounds, their use as pharmaceutically active analgetic matarials and process for their preparation | |
PL335484A1 (en) | Derivatives of heteroarylhexamide, their production and application as selective inhibitors of mip-1a being assimilated by its ccr1 receptor | |
HUP0202186A3 (en) | Benzimidazolone derivatives, process for their preparation, pharmaceutical compositions containing them and their use as phosphodiesterase inhibitors for producing pharmaceutical compositions | |
HUP0204087A3 (en) | Dihydro-1,3,5-triazine amine derivatives, process for their preparation and pharmaceutical compositions containing them and their therapeutic uses | |
HK1068336A1 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
HUP0400155A3 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
MXPA03005601A (es) | Nuevos compuestos y composiciones como inhibidores de catepsina. | |
AU2002238855A1 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
MY128896A (en) | Pharmaceutical combinations | |
CZ20011813A3 (cs) | Deriváty N-triazolylmethylpiperazinu jako antagonistické látky neurokininových receptorů, jejich výroba a léčiva | |
HUP0201710A3 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor, process for producing them and pharmaceutical compositions containing them | |
IL107208A0 (en) | A process for the preparation of a crop protection agent | |
AU2003283055A8 (en) | Opioid-receptor antagonists in transdermal systems having buprenorphine | |
GEP20053494B (en) | Crystalline Therapeutic Agent | |
HUP0203835A3 (en) | Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient | |
SI1476434T1 (sl) | Derivati piridazina, njihova uporaba kot zdravilain postopek za njihovo pripravo | |
AU2002335354A1 (en) | Indole derivatives, process for producing the same and drugs containing the same as the active ingredient | |
HUP0000407A3 (en) | Process for simultan producing n,n'-bis-(2-amino-ethyl)-1,3-propane-diamine and alkali earth-haloid salt and/or salt mixture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |